The S&P 500, Dow, and Nasdaq 100 closed with divergent movements Tuesday, as market sentiment swung between optimism over strong corporate earnings and unease over AI spending concerns and Middle East volatility. The Dow rose 1.03% to its highest level in 15 days, while the Nasdaq 100 slumped 0.98%, nearing a seven-and-a-half-week low. E-mini S&P futures edged up 0.24%, but Nasdaq futures fell 0.88% amid weakness in tech and AI-linked sectors. September E-mini Nasdaq futures plunged 0.88%, reflecting investor flight to safer havens.
Broad market momentum was bolstered by better-than-expected earnings from conglomerates like Coca-Cola, Sherwin-Williams, and Boeing, whose +4% stock jump followed a 9% revenue beat in Q2. Software stocks also gained traction as traders rotated out of oversold sectors. However, chipmakers and AI infrastructure faced a relentless rout, with Sandisk tumbling 14% and AMD shedding 8% on fears of slowing tech investment. The iShares Semiconductor ETF (SOXX) hit multi-week lows amid speculation of cooling AI demand despite robust macroeconomic data.
Energy markets stabilized as WTI crude dropped 4% to a 2024 six-week low, driven by diplomatic developments with Iran and eases in U.S. inflation pressures. This decline softened bond yields, placing downward pressure on the 10-year Treasury yield, which fell 5 basis points to 4.60%. Meanwhile, the Conference Board’s unexpected July consumer confidence decline (-1.4 points) added volatility to market forecasts. The Richmond Fed’s monthly manufacturing survey weakened to 5, below forecasts, signaling fragile industrial activity.
Global markets mirrored domestic turbulence. European indices edged sideways, but Asian markets were marred by the Nikkei-225’s 3.95% slump. Houthi militant threats to reopen attacks on Saudi oil infrastructure—including strikes on the Yanbu facilities critical to crude exports—amplified energy security fears. U.S. officials, however, hinted at progress in Iran nuclear talks, offering cautious optimism amid frayed diplomatic relations. President Trump’s indicated readiness to target Iranian nuclear sites reignited regional tensions.
Homebuilders outperformed expectations, with the S&P Composite-20 home price index rising 1.6% YoY versus a 1.3% forecast. In contrast, Wall Street edged lower as U.S. consumer confidence fell 1.4 points to 90.8, defying projections of resilience. The Richmond Fed’s manufacturing data underscored manufacturing softness, complicating hopes of a durable recovery.
Upcoming corporate highlights include Microsoft (MSFT) and Meta Platforms (META) reporting earnings ahead of the week’s climax. Bloomberg Intelligence forecasts suggest Q2 earnings could surge 23% year-over-year, with AI initiatives projected to drive nearly 60% of the S&P 500’s earnings growth. So far, 86% of S&P 500 firms have beaten Q2 estimates, matching accelerated improvement trends since AI spending ramped up.
Fed policymakers priced a 30% probability of a 25-basis-point rate hike at Wednesday’s FOMC meeting, balancing concerns about deposal inflation against technical recession risks. Meanwhile, European governments’ borrowing costs dipped further: German 10-year bond yields fell 2.9 basis points to 3.103%, UK Gilt yields dropped 5.2 basis points to 4.944%, spurred by falling Treasury yields and easing energy prices.
Cryptocurrency-linked equities stumbled as Bitcoin fell 1%, precipitating losses for digital asset proxies like Galaxy Digital (-9%) and MARA Holdings (-4%). Travel and healthcare equities provided relative stability. Route Congress (RCO) and Medtronic (MDT) reported muted results, while Nucor (NUE) surged 7% on Q2 sales that outpaced street estimates.
Corporate headlines dominated earnings season. IQVIA raised its annual revenue forecast to $17.48 billion, exceeding expectations by 2.7%. Sherwin-Williams bolstered its EPS outlook to $11.80–12.20, while Coca-Cola maintained a 9–10% EPS projection. Conversely, Amkor Technology (-24%) and Nucor’s (NUE) big gainer narrative clashed with Corning’s (-12%) downwardly revised Q3 sales guidance below central estimates.
This material is provided solely for informational purposes and does not constitute investment advice. None of the author or Barchart Staff have conflicts of interest regarding discussed securities.
